A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Phase 2
340
about 3.3 years
18+
52 sites in AL, AZ, CA +16
What this study is about
Researchers are testing two trial medicines, PF-07275315 and PF-07264660, in people with moderate to severe atopic dermatitis. It is seeking participants who have confirmed atopic dermatitis for at least 6 months and are not having an effective treatment result from medicines that are applied on skin for AD. Participants will receive either PF-07275315 or PF-07264660 or placebo as multiple shots in the clinic over the course of each Stage.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take PF-07264660
- 3.Take PF-07275315
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: The number and % of participants achieving a Percent change from baseline in EASI total score at scheduled time points, The number and % of participants with treatment emergent AEs
Dermatology